HRT Financial’s Chemours CC Stock Holding History

HRT Financial’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	+77,500	New	+$1.77M	﹤0.01%	1875

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

HRT Financial's CC Position: Q2 2026 in Review

HRT Financial sold out of Chemours (CC) in Q2 2026, closing a stake of 376,241 shares — an estimated $8.61M sold.

HRT Financial first reported a position in CC in Q1 2018 and held it in 9 quarters. The position peaked at $9.01M in Q1 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

HRT Financial reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 376,241 Chemours shares in Q2 2026, an estimated $8.61M.
HRT Financial first reported a position in Chemours in Q1 2018 and held it in 9 quarters.
HRT Financial's Chemours position peaked at $9.01M in Q1 2023.
469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.